This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Forget Clover Health (COLV), Buy 3 Non-Meme Healthcare Bets Instead
by Sapna Bagaria
Despite being hotly traded on social-media platforms, Cover Health (CLOV) offers little investment value to long-term investors.
Looking for a Growth Stock? 3 Reasons Why Molina (MOH) is a Solid Choice
by Zacks Equity Research
Molina (MOH) possesses solid growth attributes, which could help it handily outperform the market.
Select Medical's (SEM) Growth Plans to Extend US Footprint
by Zacks Equity Research
Select Medical (SEM) undertakes a series of buyouts and JVs aimed to offer an array of long-term acute care services for treating the U.S. population.
Obamacare Upheld in Recent Rulings: A Boon for Healthcare
by Sapna Bagaria
Insurers and hospital companies are now in conducive regulatory environment with the ACA getting a thumbs up from the Supreme Court.
Molina (MOH) Down 1.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth (UNH) Unit to Offer Better Care in Central New York
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum collaborates with Bassett to offer enhanced and cost-effective healthcare services to Central New York patients.
Cigna (CI) Rides on Acquisitions, Strong Capital Deployment
by Zacks Equity Research
Cigna (CI) looks well poised for growth on the back of its acquisitions, membership strength and other growth strategies.
Why Should You Hold Molina Healthcare (MOH) in Your Portfolio?
by Zacks Equity Research
Riding high on strategic measures and membership growth, Molina Healthcare (MOH) holds potential to reap benefits for investors.
The Zacks Analyst Blog Highlights: Centene Corp, Molina Healthcare, UnitedHealthGroup, Cigna Corp and HCA Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene Corp, Molina Healthcare, UnitedHealthGroup, Cigna Corp and HCA Healthcare
Health Insurers to Gain From Biden Open Enrollment Expansion
by Sapna Bagaria
Special enrollment period will be a boost to insurers??? top lines who are providing health plans on federal exchanges.
Here is Why Growth Investors Should Buy Molina (MOH) Now
by Zacks Equity Research
Molina (MOH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Zacks Analyst Blog Highlights: Continental Resources, United Parcel Service, Bruker Corp, Molina Healthcare and CDW Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Continental Resources, United Parcel Service, Bruker Corp, Molina Healthcare and CDW Corp
Top 5 Growth Picks Amid Disappointing April Jobs Data
by Nalak Das
We have narrowed down our search to five growth stocks that have popped more than 25 % year to date and still have upside left for 2021. These are: UPS, CLR, MOH, CDW, and BRKR
Select Medical (SEM) Beats on Q1 Earnings, Hikes '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) first-quarter results indicate uptick in revenues stemming from solid segmental performances except Outpatient Rehabilitation, partly offset by higher costs.
Molina Healthcare's (MOH) Q1 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter earnings gain from higher revenues and increased membership in Medicaid and Marketplace.
UnitedHealth (UNH) to Help Eligible Medicaid Members in Ohio
by Zacks Equity Research
UnitedHealth (UNH) intends to improve health outcomes of eligible Medicaid members in Ohio where it already boasts a strong presence.
Molina (MOH) to Aid Medicaid Members in Ohio Via Contract Wins
by Zacks Equity Research
Molina (MOH) is selected by the Ohio Department of Medicaid to serve beneficiaries across the state.
Magellan (MGLN) Expands in Precision Oncology With Trapelo
by Zacks Equity Research
Magellan Health (MGLN) partners Trapelo Health to offer an all-inclusive approach to value-based care in the innovative arena of precision oncology treatments.
Molina Healthcare (MOH) Up 86% in a Year: More Room to Run?
by Zacks Equity Research
Molina Healthcare (MOH) is well-poised to gain from a robust Medicare and Medicaid business, and numerous buyouts for boosting its service offerings.
Molina (MOH) Up 5.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana (HUM) Joins IBM Watson Health to Aid Member Experience
by Zacks Equity Research
Humana (HUM) teams up with IBM Watson Health to leverage the latter's conversational AI solution for providing better information to Humana Employer Group members.
Magellan Health (MGLN), Wellth Tie Up on Behavioral Change
by Zacks Equity Research
Magellan Health (MGLN) initiates a pilot program with Wellth to improve medication adherence and the general health of its members.
Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.
What's in the Offing for Centene (CNC) This Earnings Season?
by Zacks Equity Research
Centene's (CNC) Q4 results are likely to reflect escalating costs and other COVID-related factors.
Earnings Preview: Molina (MOH) Q4 Earnings Expected to Decline
by Zacks Equity Research
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.